PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,442 | +80.0% | 8,196 | 0.0% | 0.00% | – |
| Q2 2023 | $1,357 | -95.4% | 8,196 | -72.8% | 0.00% | – |
| Q1 2023 | $29,368 | -87.0% | 30,090 | -86.2% | 0.00% | – |
| Q4 2022 | $226,561 | -83.0% | 217,847 | -81.2% | 0.00% | – |
| Q3 2022 | $1,330,000 | -39.2% | 1,156,290 | -1.0% | 0.00% | – |
| Q2 2022 | $2,186,000 | -40.1% | 1,168,413 | -2.9% | 0.00% | – |
| Q1 2022 | $3,648,000 | -29.7% | 1,203,713 | -12.3% | 0.00% | -100.0% |
| Q4 2021 | $5,187,000 | -42.2% | 1,372,495 | -21.0% | 0.00% | 0.0% |
| Q3 2021 | $8,981,000 | +39.9% | 1,737,126 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $6,419,000 | +204.8% | 1,675,969 | +104.6% | 0.00% | – |
| Q1 2021 | $2,106,000 | -1.5% | 819,176 | -4.2% | 0.00% | – |
| Q4 2020 | $2,138,000 | +596.4% | 854,932 | +476.8% | 0.00% | – |
| Q3 2020 | $307,000 | +52.0% | 148,209 | +127.6% | 0.00% | – |
| Q2 2020 | $202,000 | -77.9% | 65,113 | -83.7% | 0.00% | – |
| Q1 2020 | $912,000 | -68.9% | 400,233 | -50.7% | 0.00% | -100.0% |
| Q4 2019 | $2,936,000 | +240.2% | 811,211 | +220.6% | 0.00% | – |
| Q3 2019 | $863,000 | +637.6% | 253,055 | +922.8% | 0.00% | – |
| Q2 2019 | $117,000 | +31.5% | 24,741 | -7.4% | 0.00% | – |
| Q1 2019 | $89,000 | -69.1% | 26,706 | -75.4% | 0.00% | – |
| Q4 2018 | $288,000 | -60.4% | 108,353 | -16.6% | 0.00% | – |
| Q3 2018 | $727,000 | +13.4% | 129,910 | +2.8% | 0.00% | – |
| Q2 2018 | $641,000 | -90.6% | 126,341 | -87.4% | 0.00% | -100.0% |
| Q1 2018 | $6,829,000 | +239.1% | 1,001,258 | +275.2% | 0.00% | +100.0% |
| Q4 2017 | $2,014,000 | +57.3% | 266,825 | +20.1% | 0.00% | – |
| Q3 2017 | $1,280,000 | -3.6% | 222,229 | -15.4% | 0.00% | – |
| Q2 2017 | $1,328,000 | +33.1% | 262,579 | -31.6% | 0.00% | – |
| Q1 2017 | $998,000 | +94.9% | 383,834 | +5.3% | 0.00% | – |
| Q4 2016 | $512,000 | +276.5% | 364,368 | +390.2% | 0.00% | – |
| Q3 2016 | $136,000 | – | 74,330 | +74230.0% | 0.00% | – |
| Q2 2016 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |